BDPTD
BioAdaptives, Inc. investigates, markets, and distributes natural plant, algal, and mushroom-based products and medical devices for humans and animals. It offers nutraceutical products, such as dietary supplements. The company offers PluriPain, a fast acting long lasting natural pain relief formulation; PrimiLungs; MindNMemory, a nootropic formulation that enhances memory, focus, mental clarity, … Read more
BDPTD (BDPTD) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.103x
Based on the latest financial reports, BDPTD (BDPTD) has a cash flow conversion efficiency ratio of 0.103x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-151.31K) by net assets ($-1.47 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
BDPTD - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how BDPTD's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
BDPTD Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BDPTD ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sierra Cables PLC
CM:SIRAN0000
|
N/A |
|
Vector 21 Holdings Inc
PINK:VHLD
|
0.026x |
|
TC UNTERHALTUNGSELE (TCU.SG)
STU:TCU
|
N/A |
|
SCS
WAR:SCS
|
-0.003x |
|
CNC Capital Viet Nam JSC
VN:KSQ
|
N/A |
|
National Drilling
EGX:NDRL
|
N/A |
|
Gaussin SA
MU:1KK1
|
N/A |
|
Whitewater Acquisition Corp.
V:WWA-P
|
0.005x |
Annual Cash Flow Conversion Efficiency for BDPTD (2020–2024)
The table below shows the annual cash flow conversion efficiency of BDPTD from 2020 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-1.46 Million | $-249.52K | 0.170x | +25.42% |
| 2023-12-31 | $-1.65 Million | $-223.77K | 0.136x | -13.20% |
| 2022-12-31 | $-1.45 Million | $-227.26K | 0.157x | +7.87% |
| 2021-12-31 | $-1.09 Million | $-158.65K | 0.145x | +87.23% |
| 2020-12-31 | $-1.38 Million | $-106.89K | 0.078x | -- |